Lv3
360 积分 2024-06-26 加入
LBO-004 Safety, pharmacokinetics, and clinical activity of HRX215 after hepatectomy due to colon carcinoma metastases: interim results from pilot cohort of a 1b/2a clinical trial
1个月前
已完结
Current drug options for raising HDL cholesterol
1个月前
已完结
Raising HDL cholesterol
1个月前
已完结
Epidemiology of cardiovascular–kidney–metabolic syndrome
1个月前
已完结
Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats
2个月前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
2个月前
已完结
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
5个月前
已关闭
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
5个月前
已完结
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
5个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
5个月前
已完结
皖公网安备34019202002308
